Combinatorial Chemistry and Library Design

Slides:



Advertisements
Similar presentations
1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
Advertisements

Distributed Drug Discovery Indiana University Purdue University, Indianapolis.
Analysis of High-Throughput Screening Data C371 Fall 2004.
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
A Multiobjective Approach to Combinatorial Library Design Val Gillet University of Sheffield, UK.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Personalia: Pre-Sheffield Batchelor’s degree in Chemistry at Oxford Pre-university job in my local public library system Chemistry or information science?
Lipinski’s rule of five
Establishing a Successful Virtual Screening Process Stephen Pickett Roche Discovery Welwyn.
 Used extensively in relation with drug discovery  Principle of Combinatorial Chemistry ◦ Generation of Compound Libraries from Molecular Building blocks.
Introduction to Proteomics. First issue of Proteomics- Jan. 1, 2001.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Summary Molecular surfaces QM properties presented on surface Compound screening Pattern matching on surfaces Martin Swain Critical features Dave Whitley.
Bioinformatics: a Multidisciplinary Challenge Ron Y. Pinter Dept. of Computer Science Technion March 12, 2003.
Luddite: An Information Theoretic Library Design Tool Jennifer L. Miller, Erin K. Bradley, and Steven L. Teig July 18, 2002.
THE BUILDING BLOCKS OF LIFE. BUILT FOR YOU Putting Engineering back into Protein Engineering Jun Liao, UC Santa Cruz Manfred K. Warmuth, UC Santa Cruz.
2DS01 Statistics 2 for Chemical Engineering lecture 5.
1 BrainWave Biosolutions Limited Accelerating Life Science Research through Technology.
Optical Isomerism  Optical isomers rotate plane polarised light in opposite directions: one rotates light clockwise and the other anticlockwise.  A mixture.
RAPID: Randomized Pharmacophore Identification for Drug Design PW Finn, LE Kavraki, JC Latombe, R Motwani, C Shelton, S Venkatasubramanian, A Yao Presented.
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
Drug Action and Drug Design. Stereoisomers Stereoisomers are isomers with the same molecular formula AND the same structural formula, but a different.
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Cédric Notredame (30/08/2015) Chemoinformatics And Bioinformatics Cédric Notredame Molecular Biology Bioinformatics Chemoinformatics Chemistry.
Catalyst design driven by fundamental research How do we extrapolate from molecular (picoscale) and nanoscale fundamentals to operating catalytic systems?
Knowledgebase Creation & Systems Biology: A new prospect in discovery informatics S.Shriram, Siri Technologies (Cytogenomics), Bangalore S.Shriram, Siri.
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Similarity Methods C371 Fall 2004.
NIH Roadmap and Chemoinformatics Jeffery Loo NLM Associate Fellow Welch Library Journal Club 2004/12/7.
A genetic algorithm for structure based de-novo design Scott C.-H. Pegg, Jose J. Haresco & Irwin D. Kuntz February 21, 2006.
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
D9 Drug design Compound libraries Combinatorial and parallel chemistry
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
Drug Design Geometrical isomerism Chirality
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Function first: a powerful approach to post-genomic drug discovery Stephen F. Betz, Susan M. Baxter and Jacquelyn S. Fetrow GeneFormatics Presented by.
Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,
Synthesis Make me a molecule Chemistry Biology Materials.
Open source software and web services for designing therapeutic molecules G. P. S. Raghava, Head Bioinformatics Centre, Institute of Microbial Technology,
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
ChemBank Building a Public Web Resource Using Daycart Erik Brauner Head of Chemical and Biological Computing Harvard Institute of Chemistry and Cell Biology.
Dial-a-Molecule A Grand Challenge for Chemistry and Chemical Engineering Prof. Richard Whitby University of Southampton.
Combinatorial Chemistry. Synthesis of many structures (diversity) combinatorial technology, combinatorial library molecular diversity What is Combinatorial.
Drug Action and Design IB Chemistry Option D: Drugs and Medicines.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
ECCR Overview/MLSCN. NIH Roadmap Series of initiatives designed to pursue major opportunities in biomedical research and gaps in current knowledge that.
Selecting Diverse Sets of Compounds C371 Fall 2004.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Design of a Compound Screening Collection Gavin Harper Cheminformatics, Stevenage.
Use of Machine Learning in Chemoinformatics
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
신기술 접목에 의한 신약개발의 발전전망과 전략 LGCI 생명과학 기술원. Confidential LGCI Life Science R&D 새 시대 – Post Genomic Era Genome count ‘The genomes of various species including.
Molecular Modeling in Drug Discovery: an Overview
TIDEA Target (and Lead) Independent Drug Enhancement Algorithm.
Combinatorial Chemistry
Designing Drugs Virtually P14D461P - Arni B. Hj. Morshidi P14D389P - Anisah Bt Ismail P14D397P - Syarifah Rohaya Bt Wan Idris P14D394P - Dayang Adelina.
Natural products from plants
Combinatorial chemistry
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Drug Design Geometrical isomerism Chirality
Drug Action and Design IB Chemistry Option D: Drugs and Medicines
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Introduction of Combinatorial Chemistry
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Asymmetric Synthesis Dr. Mirza Shahed Baig.
Virtual Screening.
Statistics 2 for Chemical Engineering lecture 5
Presentation transcript:

Combinatorial Chemistry and Library Design Chemical Informatics Lecture Based largely on the C&EN story published October 27, 2003, pp. 45 ff.

Combinatorial Chemistry Definition: the synthesis of chemical compounds as ensembles (libraries) and the screening of those libraries for compounds with desirable properties Potentially speedy route to new drugs, catalysts, and other compounds and materials Technique invented in the late 1980s and early 1990s to enable tasks to be applied to many molecules simultaneously

Combichem Techniques Tools Solid-phase synthesis Resins Reagents (Monomers) Linkers Screening methods

Combichem Methods Use of solid supports for peptide synthesis led to wider applications Products from one reaction are divided and reacted with other reagents in succession Split-mix scheme: library size increases exponentially

DIVERSE AND FOCUSED LIBRARIES Many early disappointments led to: Design of smaller, more focused libraries with much information about the target May concentrate on a family of targets (e.g., proteases or kinases) Use of more diverse libraries when little is known about the target “Primary screening libraries Give broad coverage of chemistry space Selection of compounds with “drug-like” physicochemical properties

Problems with Early Combichem Libraries Many compounds had undesirable properties: Size Solubility Inappropriate functional groups

Criticism of the Technique Early libraries often based on a single skeleton (basic structure) Limited number of skeletons accessible Individual library members were structurally similar Compounds tended to be achiral or racemic Initial emphasis on creating mixtures of very large numbers of compounds now out of favor

LIBRARY ENUMERATION Process by which the molecular graphs of the product molecules are generated automatically from lists of reagents (using connection tables or SMILES strings) Fragment marking – Central core template and one or more R groups Reaction transform approach – Transform is a computer-readable representation of the reaction mechanism: atom mapping

Advantages/Disadvantages Fragment marking generally a very fast enumeration once core template and R group fragments are defined. May be difficult to generate the core and to generate fragments automatically

Combichem Techniques (cont’d) Markush-based approaches to enumeration Ideally suited when a common core can be identified Certain subsets of the product structures may have features in common

COMBINATORIAL LIBRARY DESIGN STRATEGIES Two Main Strategies: Monomer-based selection: Subsets of monomers selected without consideration of the products Product-based selection: Properties of the resulting product molecules influence the selection of the monomers Much more computationally demanding than monomer-based selection, but can be more effective when wanting to optimize the properties of a library as a whole

APPROACHES TO PRODUCT-BASED LIBRARY DESIGN Identify lists of potential reagents, filter them as needed, and enumerate the virtual library Subject virtual library to virtual screening to evaluate and score each structure Select reagents from results of virtual screening plus additional criteria (degree of structural diversity required, degree of similarity or dissimilarity to existing collections) Usually done with optimization techniques (e.g., genetic algorithms or simulated annealing)

Alternatives to Product-Based Library Design Molecule-based methods Appropriate for targeted or focused libraries Relatively fast, especially when combined with optimization based on 2D properties

MULTIOBJECTIVE LIBRARY DESIGN Optimizes multiple properties simultaneously Balances diversity and focus Could search for drug-like properties Multiobjective Genetic Algorithm (MOGA)

PRACTICAL EXAMPLES OF LIBRARY DESIGN See examples in the text for Structure-Based Library Design Library Design in Lead Optimization

TRENDS Design of smaller, more focused libraries with as much information about the therapeutic target as possible May use docking methods if target structure is known Use pharmacophoric methods, 2D or physicochemical properties if some actives are known Focus on compounds with “drug-like” physicochemical properties

New Combichem Techniques Current emphasis on arrays of fewer, well-characterized compounds Movement toward complex natural-product-like compounds

Recent Advances Natural-product-like libraries Dynamic combinatorial chemistry Combinatorial optimization of catalysts Multi-component reactions

New Approaches Use biologically relevant building blocks Use branching networks of reactions Produce libraries of natural-product-like compounds Make all possible combinations of both core skeletal structures and peripheral groups

New Approaches Dynamic Combichem (DCC) Used to ID molecules that bind with high affinity to macromolecular receptors OR Synthetic receptors that bind tightly to small molecules Uses equilibrium forces to amplify compounds that bind well to targets

New Approaches Combi Catalysis To discover and optimize catalysts Novel Methods for Combinatorial Synthesis New linkages for solid-phase synthesis New multi-component reactions

New Combichem Techniques Make compounds in parallel Test them in parallel Obtain new properties rapidly Discrete compounds are produced by parallel synthesis or by mixing synthesis with directed sorting

Benefits to the Pharmaceutical Industry Provides a stimulus for robot-controlled and immobilization strategies that allow high-throughput and multiple parallel approaches to drug discovery

Benefits to Materials Science Combinatorial approaches now being applied to solid-state and materials applications Also to search for new catalysts

NIH Roadmap http://nihroadmap.nih.gov/ Roadmap for Medical Research in the 21st Century Includes: Molecular Libraries and Imaging NIH will assemble a huge combinatorial library as a source of new drug candidates PubChem Database http://pubchem.ncbi.nlm.nih.gov/

CombiChem Web Sites CombiChem Lab http://www.combichemlab.com Combinatorial Chemistry and High Throughput Screening (Wendy Warr) http://www.warr.com/ombichem.html